News

InnoCare Pharma and ArriVent Biopharma announced a clinical development collaboration to evaluate the combination of InnoCare’s novel SHP2 (Src Homology 2 domain containing protein…
Read More...

TheracosBio announced that Brenzavvy (bexagliflozin), an FDA-approved oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, is now available by prescription through the Mark Cuban Cost…
Read More...

BeiGene, a global biotechnology company, today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s supplemental new drug application (sNDA) for…
Read More...

LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced a clinical supply agreement with AstraZeneca in…
Read More...

Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio (inclisiran) to enable earlier use in patients with elevated LDL-C who…
Read More...

Astellas Pharma Inc. announced that it has successfully completed the acquisition of IVERIC bio, Inc. with respect to the announcement on April 30, 2023, through its indirect…
Read More...

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has signed a Memorandum of Understanding…
Read More...

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company's Biologics License Application (BLA) for…
Read More...

TiumBio Co., Ltd. and Hansoh Pharmaceutical Group Co., Ltd. announced that the China National Medical Products Administration (NMPA) approved Hansoh's Investigational New Drug (IND)…
Read More...

VBI Vaccines Inc. announced the expansion of its hepatitis B (HBV) partnership with Brii Biosciences. Through two license and collaboration agreements, Brii Bio expanded its exclusive…
Read More...

Lifera, a biopharmaceutical company in Saudi Arabia together with Sanofi, one of the world's leading pharmaceutical companies specializing in vaccine development and Arabio announced…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announces an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing…
Read More...

Vertex Pharmaceuticals announced that the European Commission has granted approval for the label extension of ORKAMBI (lumacaftor/ivacaftor) for the treatment of children with cystic…
Read More...

F-star Therapeutics, an invoX company, announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda. The collaboration will leverage F-star’s…
Read More...

Baudax Bio, Inc. announced the acquisition of TeraImmune, a privately held a biotechnology company focused on discovery and development of novel Treg-based cell therapies for autoimmune…
Read More...

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, and its wholly-owned commercialization subsidiary Tonix Medicines, Inc. (Tonix Medicines), announced it has completed…
Read More...

Eli Lilly and Company and Sigilon Therapeutics, Inc. announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seeks to develop functional cures…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with platinum-based chemotherapy for the neoadjuvant treatment of…
Read More...

Sangamo Therapeutics, Inc., a genomic medicine company, and Voyager Therapeutics, Inc. announced the parties have entered into a definitive license agreement for a potential treatment…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for…
Read More...